← Leaderboards
Lora L Sabin
Boston University Medical Campus
$2,935,918
Attributed
$5,698,223
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,698,223 · 4
By mechanism
R01$4,357,416 · 2
R34$1,340,807 · 2
Top collaborators
- Catherine Orrell9 shared
- Ingrid T. Katz3 shared
- Lisa Jean Messersmith3 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Eugene R Declercq$3,162,272
- Lisa Jean Messersmith$335,203
- Max O'Donnell$9,472,250
- Lawrence Camdon Long$864,871
Others in their field
Top investigators on “Antiretroviral Therapy”
- James Dennis Neaton · Northwestern University$279,044,427
- Lawrence Corey · Fred Hutchinson Cancer Center$278,220,635
- Constance Ann Benson · University Of California, San Diego$241,336,455
- Carol Nesel · Westat$188,148,170
- Judith S. Currier · University Of California Los Angeles$182,467,520
- Barbara Driver · Westat, Inc.$170,789,549
Research focus
Antiretroviral TherapyDesignCaringInnovationFutureEvidence BaseEpidemicParticipantEffectivenessCessation Of LifeMotivationSurveysTechnologyClinicCompliance BehaviorProgramsEffective InterventionInterviewPolicy MakerSuccessAdherenceCommunitiesHigh RiskClinical Practice
Grant awards (15)
The SUSTAIN 2 study - SUStained HIV Treatment for Adherence After Interruption in Care$449,181
R01 · FY2025 · MH
Supporting Sustained HIVTreatment Adherence after Initiation (SUSTAIN)$392,957
R01 · FY2025 · MH · contact PI
The SUSTAIN 2 study - SUStained HIV Treatment for Adherence After Interruption in Care$260,740
R01 · FY2025 · MH
Supporting Sustained HIVTreatment Adherence after Initiation (SUSTAIN)$159,336
R01 · FY2025 · MH · contact PI
The SUSTAIN 2 study - SUStained HIV Treatment for Adherence After Interruption in Care$780,447
R01 · FY2024 · MH
Supporting Sustained HIVTreatment Adherence after Initiation (SUSTAIN)$534,950
R01 · FY2024 · MH · contact PI
Supporting Sustained HIVTreatment Adherence after Initiation (SUSTAIN)$532,562
R01 · FY2023 · MH · contact PI
Supporting Sustained HIVTreatment Adherence after Initiation (SUSTAIN)$560,193
R01 · FY2022 · MH · contact PI
Supporting Sustained HIVTreatment Adherence after Initiation (SUSTAIN)$687,050
R01 · FY2021 · MH · contact PI
Improving ART Retention and Adherence in Uganda, the WiseMama Study$115,258
R34 · FY2016 · MH
Improving ART Retention and Adherence in Uganda, the WiseMama Study$227,747
R34 · FY2015 · MH
Improving ART Retention and Adherence in Uganda, the WiseMama Study$327,400
R34 · FY2014 · MH
China Adherence through Technology Study (CATS)$115,397
R34 · FY2014 · DA · contact PI
China Adherence through Technology Study (CATS)$240,850
R34 · FY2013 · DA · contact PI
China Adherence through Technology Study (CATS)$314,155
R34 · FY2012 · DA · contact PI